FGF21 plays a pivotal role in modulating inflammatory responses, as evidenced by the development of various inflammatory disorders in FGF21-deficient conditions, including non-alcoholic fatty liver disease (NAFLD) and pancreatitis (31, 32). Here, FGF21 is linked to metabolic dysfunction-associated steatotic liver disease.